LumiraDx Receives FDA EUA for its COVID-19 Antibody Test
LumiraDx has announced receiving FDA EUA for its SARS-CoV-2 Ab test, which is used to help identify an adaptive immune response to SARS-CoV-2.
Read MorePosted by Chris Wolski | Aug 5, 2021 | Covid 19, POC Rapid Assays |
LumiraDx has announced receiving FDA EUA for its SARS-CoV-2 Ab test, which is used to help identify an adaptive immune response to SARS-CoV-2.
Read MorePosted by Chris Wolski | Aug 4, 2021 | Covid 19 |
Researchers have shown that children infected with SARS-CoV-2 also show breath metabolite changes that are largely different from adults.
Read MorePosted by Chris Wolski | Aug 3, 2021 | Urinalysis & Toxicology |
Patients undergoing surgery and other procedures are routinely pre-screened for UTIs, but the vast majority of these tests are not needed.
Read MorePosted by Chris Wolski | Jul 28, 2021 | Infectious Diseases |
Galaxy Diagnostics, Inc. has launched a Bartonella IFA Serology (IgG) Panel commercially available for human health testing.
Read MorePosted by Chris Wolski | Jul 21, 2021 | Covid 19 |
In the early days of the pandemic, scientists at Virginia Tech pivoted from academic research and created a COVID-19 testing laboratory.
Read More